SinocellTech
IPOBeijing, China · Founded 2002
- Headquarters
- Beijing
- Founded
- 2002
- Business Model
- B2B
- Website
- sinocelltech.com
- Last Round
- Series AJan 2017
- Rounds
- 1
About
Beijing Sinocelltech Biotechnology Group Co., Ltd. (Shanghai Stock Exchange: 688520) is a Chinese biopharmaceutical company founded by Dr. Xie Liangzhi, an internationally recognized expert in biopharmaceutical research and industrialization who led China's major new drug innovation program. The company focuses on the research, development, and industrialization of monoclonal antibodies, recombinant proteins, and vaccines, with products spanning prevention (including an HPV vaccine) and treatment areas such as hemophilia and autoimmune disease.
Summary
SinocellTech is a Healthcare company based in Beijing, China, founded in 2002. Its most recent funding was a Series A round in Jan 2017. Investors include Qiming VP.
Tech & App Stack
1 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jun 2020
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...